Stephens & Co. Maintains Overweight on AvePoint, Raises Price Target to $17
Stephens & Co. analyst Todd Weller maintains AvePoint (NASDAQ:AVPT) with a Overweight and raises the price target from $16 to $17.
Stocks · News reference
AvePoint Q2 EPS $0.12 Beats $0.04 Estimate, Sales $124.495M Beat $121.367M Estimate
AvePoint (NASDAQ:AVPT) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.04 by 200 percent. This is a 1100 percent increase over earnings of $0.01 per share from the same
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Shares of software companies are trading higher after AI executives from firms including Anthropic, OpenAI and SpaceXAI signaled that the industry's growth may have to be slowed, which may limit threats to software vendors.
Scotiabank Maintains Sector Outperform on AvePoint, Raises Price Target to $15
Scotiabank analyst Joe Vandrick maintains AvePoint (NASDAQ:AVPT) with a Sector Outperform and raises the price target from $12 to $15.
TD Cowen Maintains Buy on AvePoint, Raises Price Target to $15
TD Cowen analyst Derrick Wood maintains AvePoint (NASDAQ:AVPT) with a Buy and raises the price target from $14 to $15.